• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐匿性乳腺癌术后的手术治疗趋势及原发肿瘤定位:一项基于日本国家临床数据库-乳腺癌登记处的研究。

Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry.

机构信息

Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan.

Department of Breast and Endocrine Surgical Oncology, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Breast Cancer. 2022 Jul;29(4):698-708. doi: 10.1007/s12282-022-01348-y. Epub 2022 Mar 22.

DOI:10.1007/s12282-022-01348-y
PMID:35316446
Abstract

BACKGROUND

Occult breast cancer (OBC) is classified as carcinoma of an unknown primary site, and the adequate therapy for OBC remains controversial. This retrospective study aimed to reveal the transition in breast cancer therapy and the frequency of primary breast tumors after resection in clinical OBC (cT0N+) patients using the Japanese Breast Cancer Registry database.

METHODS

We enrolled OBC patients with cT0N+ from the registry between 2010 and 2018. On the basis of the period of diagnosis, OBC patients were divided into the following two groups: 2010-2014 and 2015-2018. We described the transition in treatments and tumor characteristics. After breast resection, the frequency of pathological identification of primary tumors and tumor sizes was assessed.

RESULTS

Of the 687,468 patients registered, we identified 148 cT0N+ patients with a median age of 61 years. Of these patients, 64.2% (n = 95) received breast surgery (2010-2014: 79.1%, 2015-2018: 50.0%). Axillary lymph node dissection was performed in 92.6% (n = 137, 2010-2014: 91.6%, 2015-2018: 93.4%). The breast tumor size in the resected breast was 0-7.0 cm (median: 0 cm, 2010-2014: 0-7.0 cm [median: 0 cm], 2015-2018: 0-6.2 cm [median: 0 cm]). The pathological identification rate of the primary tumor was 41.1% (n = 39, 2010-2014: 40.4%, 2015-2018: 42.1%).

CONCLUSIONS

Breast surgery for cT0N+ decreased between 2010 and 2018. Despite the high identification rate of primary tumors, most tumors were small, and there was no significant change in the identification rate or invasive diameter of the identified tumors after 2010.

摘要

背景

隐匿性乳腺癌(OBC)被归类为不明原发灶的癌,OBC 的适当治疗仍存在争议。本回顾性研究旨在利用日本乳腺癌登记数据库揭示临床隐匿性乳腺癌(cT0N+)患者的乳腺癌治疗转变以及切除后原发性乳腺肿瘤的发生频率。

方法

我们招募了 2010 年至 2018 年登记处的 cT0N+OBC 患者。根据诊断时间,OBC 患者分为以下两组:2010-2014 年和 2015-2018 年。我们描述了治疗方法的转变和肿瘤特征。乳房切除术后,评估原发性肿瘤的病理识别频率和肿瘤大小。

结果

在登记的 687468 名患者中,我们确定了 148 名 cT0N+患者,中位年龄为 61 岁。其中,64.2%(n=95)接受了乳房手术(2010-2014 年:79.1%,2015-2018 年:50.0%)。92.6%(n=137)行腋窝淋巴结清扫术(2010-2014 年:91.6%,2015-2018 年:93.4%)。切除乳房中的乳腺肿瘤大小为 0-7.0cm(中位数:0cm,2010-2014 年:0-7.0cm[中位数:0cm],2015-2018 年:0-6.2cm[中位数:0cm])。原发性肿瘤的病理识别率为 41.1%(n=39,2010-2014 年:40.4%,2015-2018 年:42.1%)。

结论

2010 年至 2018 年间,cT0N+的乳房手术减少。尽管原发性肿瘤的识别率较高,但大多数肿瘤较小,2010 年后,识别肿瘤的比例或浸润直径无明显变化。

相似文献

1
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry.隐匿性乳腺癌术后的手术治疗趋势及原发肿瘤定位:一项基于日本国家临床数据库-乳腺癌登记处的研究。
Breast Cancer. 2022 Jul;29(4):698-708. doi: 10.1007/s12282-022-01348-y. Epub 2022 Mar 22.
2
Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.隐匿性乳腺癌伴腋窝淋巴结转移患者的治疗和生存:一项全国性回顾性研究。
J Surg Oncol. 2014 Sep;110(3):270-4. doi: 10.1002/jso.23644. Epub 2014 May 26.
3
Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes.隐匿性乳腺癌可能起源于腋窝淋巴结中存在的异位乳腺组织。
Breast Cancer Res Treat. 2018 Nov;172(1):1-7. doi: 10.1007/s10549-018-4898-4. Epub 2018 Jul 20.
4
Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI.乳腺 MRI 阴性的隐匿性乳腺癌腋窝淋巴结转移保乳治疗的结果。
Breast. 2020 Feb;49:63-69. doi: 10.1016/j.breast.2019.10.017. Epub 2019 Nov 6.
5
Management of Male Patients With Occult Breast Cancer: Analysis of the National Cancer Database.男性隐匿性乳腺癌患者的管理:国家癌症数据库分析。
J Surg Res. 2024 Jan;293:685-692. doi: 10.1016/j.jss.2023.08.053. Epub 2023 Oct 13.
6
Annual report of the Japanese Breast Cancer Registry for 2017.2017 年日本乳腺癌注册中心年度报告。
Breast Cancer. 2020 Sep;27(5):803-809. doi: 10.1007/s12282-020-01139-3. Epub 2020 Jul 24.
7
Prognostic analysis of survival in small breast cancers.小乳腺癌生存的预后分析
J Am Coll Surg. 1998 May;186(5):562-9. doi: 10.1016/s1072-7515(98)00076-3.
8
Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.T1期乳腺癌患者肿瘤大小及腋窝淋巴结受累情况与预后的相关性
Cancer. 1998 Dec 15;83(12):2502-8.
9
Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer Database.影响隐匿性乳腺癌伴腋窝淋巴结转移患者管理和预后的因素:国家癌症数据库分析。
Ann Surg Oncol. 2017 Oct;24(10):2907-2914. doi: 10.1245/s10434-017-5928-x. Epub 2017 Aug 1.
10
Clinicopathologic characteristics of malignant non-hematopoietic tumors first presented as an axillary mass with emphasis on occult breast carcinoma.以腋窝肿块为首发表现的恶性非造血系统肿瘤的临床病理特征,重点探讨隐匿性乳腺癌。
Int J Clin Oncol. 2020 Feb;25(2):292-300. doi: 10.1007/s10147-019-01555-2. Epub 2019 Oct 4.

引用本文的文献

1
Annual report of National Clinical Database-Breast Cancer Registry in 2021: characteristics categorized by body mass index and menopause status.《2021年国家临床数据库-乳腺癌登记处年度报告:按体重指数和绝经状态分类的特征》
Breast Cancer. 2025 Apr 21. doi: 10.1007/s12282-025-01698-3.
2
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry-clinical implications including chemosensitivity of breast cancer with low estrogen receptor expression.2022年日本乳腺癌统计数据:国家临床数据库 - 乳腺癌登记处年度报告 - 包括低雌激素受体表达乳腺癌化疗敏感性在内的临床意义
Breast Cancer. 2025 Mar;32(2):217-226. doi: 10.1007/s12282-025-01671-0. Epub 2025 Feb 6.
3

本文引用的文献

1
Occult carcinoma of the breast.乳腺隐匿性癌
Surg Gynecol Obstet. 1954 Mar;98(3):302-8.
Clinicopathologic features and genomic profiling of female axillary lymph node metastases from adenocarcinoma or poorly differentiated carcinoma of unknown primary.
女性腋窝淋巴结转移性腺癌或未分化癌不明原发灶的临床病理特征和基因组分析。
J Cancer Res Clin Oncol. 2024 May 15;150(5):256. doi: 10.1007/s00432-024-05783-6.
4
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan.2020年国家临床数据库-乳腺癌登记处年度报告:日本老年乳腺癌患者的10年死亡率。
Breast Cancer. 2024 Mar;31(2):179-184. doi: 10.1007/s12282-023-01532-8. Epub 2024 Jan 5.
5
Annual report of the Japanese Breast Cancer Registry for 2019.2019 年日本乳腺癌登记报告。
Breast Cancer. 2024 Jan;31(1):16-23. doi: 10.1007/s12282-023-01526-6. Epub 2023 Dec 4.
6
Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients.使用机器学习算法的预后模型及隐匿性乳腺癌患者的治疗结果
J Clin Med. 2023 Apr 24;12(9):3097. doi: 10.3390/jcm12093097.
7
Survival analysis and nomogram for early-stage occult breast cancer with positive lymph nodes based on the SEER database.基于监测、流行病学和最终结果(SEER)数据库的早期隐匿性伴淋巴结阳性乳腺癌的生存分析与列线图
Ann Transl Med. 2022 Dec;10(24):1351. doi: 10.21037/atm-22-5701.
8
Prognostic Factors and a Model for Occult Breast Cancer: A Population-Based Cohort Study.隐匿性乳腺癌的预后因素及模型:一项基于人群的队列研究
J Clin Med. 2022 Nov 17;11(22):6804. doi: 10.3390/jcm11226804.